2Nakai Y, lsayama H, Sasaki T, et al. Impact of S - 1 on the survival of patients with advanced pancreatic cancer[ J]. Pancreas,2010,39 (7) :989 -993.
3Strumberg D, Bergmann L, Graeven U, et al. First - line treatment of patients with metastatic pancreatic cancer: results of a Phase II trial with S - 1 ( CESAR - Study group) [J]. Int J Clin Pharmacol Ther,2010,48 (7) :470 - 472.
2Burris HA,Moore MJ,Andersen J,et al.Improvements insurvival and clinical benefit with gemcitabine as first-time therapyfor patients with advanced pancreas cancer:arandomized trial[J].ClinOncol,1997,15(6):2403-2413.
3DasP,Wolff RA.Concurrent capecitabine and upper abdominalradiation therapy is well to lerated[J].Radiat Oncol,2006,1:41.
4Mehta VK,Poen JC,Ford JM,et al.Protracted venous infusion 5-fluorouracil with concomitant radiotherapy compared with bolusOncol,2001,24(2):155-159.
5Boz G,De Paoli A,innocente R,et al.Radiotherapy andcontinuous Infusion 5-fluorouracil in patients with nonresectablepancreatic carcinoma[J].Int J Radiat Oncol Biolphys,2001,51(3):736-740.
6Crane CH,Abbruzzese JL,Evans DB,et al.Is the therapeuticindex Better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreaticcancer[J]?Int J Radiat Oncol Biolphy,2002,52(5):1293-1302.
7Shinchi H,Nakamura K,Noma1 N,et al.Phase-Ⅰtrial of oralfluoro pyrimidine anticancer agent(S-1)with concurrentradiotherapy in patients with unvesectable pancreatic cancer[J].British Journal of Cancer,2007,96(9):1353-1357.
8Paulino AC,Latona C.Unresectable adenocarcinoma of the pan-creas patterns of failure and treatment results[J].Cancer,2000,18(4):309.
9Shinchi H,Takao S,Noma H,et al.Lengh and quality of survivalafter external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectahal pancreatic cancer[J].Int J Radiat Oncol Biol Phys,2002,53(1):148-149.
